ストックスクリーナーアプリを入手
5.02
3.93%
0.19
アフターアワーズ：
5.00
-0.02
-0.40%
Polypid Ltd (PYPD) 最新ニュース
PolyPid Q1 earnings call highlights - MSN
PolyPid (PYPD) Jumps 3.93% as Stock Approaches Key Resistance LevelSupport Level Bounce - Newser
PolyPid to Participate in the Craig-Hallum 23rd Annual Institutional Investor Conference - Yahoo Finance
PolyPid’s Earnings Call Signals Tightrope to Approval - TipRanks
PolyPid Ltd stock (US70450B1035): pivotal Phase 3 data and Nasdaq listing shift in focus - AD HOC NEWS
PolyPid Submits D-PLEX100 New Drug Application to FDA - HarianBasis.co
PolyPid Ltd.Ordinary Shares (NQ: PYPD - FinancialContent
PolyPid stock (US70450B1035): NDA submission advances D-PLEX100 toward FDA review - AD HOC NEWS
PolyPid Ltd. (NASDAQ:PYPD) Q1 2026 Earnings Call Transcript - Insider Monkey
PYPD Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
PolyPid Earnings Call: NDA Momentum Amid Cash Strain - TipRanks
PolyPid Q1 Earnings Call Highlights - sharewise.com
PolyPid Ltd. Q1 2026 Earnings Call Summary - Yahoo Finance
PolyPid Q1 2026 Earnings Call Transcript - MarketBeat
PYPD: NDA submission for D-PLEX100 nears completion as financials improve and commercialization advances - TradingView
PolyPid Ltd reports results for the quarter ended December 31Earnings Summary - TradingView
PolyPid Q1 2026 Earnings Call: Complete Transcript - Benzinga
[6-K] PolyPid Ltd. Current Report (Foreign Issuer) | PYPD SEC FilingForm 6-K - Stock Titan
PolyPid Provides Corporate Update and Reports First Quarter 2026 Financial Results - marketscreener.com
PolyPid Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
PolyPid Ltd (PYPD) Q1 2026 Earnings Call Highlights: Strategic Advances Amid Financial Challenges By GuruFocus - Investing.com Canada
Rosalind Advisors/Fund report 9.9% in PolyPid (PYPD) via warrants and shares - Stock Titan
TradingKey - TradingKey
PolyPid Ltd expected to post a loss of 43 cents a shareEarnings Preview - TradingView
Number of shareholders of PolyPid Ltd. – NASDAQ:PYPD - TradingView
How sustainable is PolyPid (PYPD) profit margins? (Smart Money Exits) 2026-05-08Street Ratings - newser.com
PolyPid (PYPD.US) will release its earnings report before the market opens on May 13. - Moomoo
PolyPid to Announce First Quarter 2026 Financial Results on May 13 and Host Conference Call at 8:30 AM ET - geneonline.com
PolyPid to Report First Quarter 2026 Financial Results and Operational Highlights on May 13, 2026 - The Manila Times
Aurum holds 5,001,561 shares in Polypid Ltd. (PYPD) with exercisable warrants - Stock Titan
AIGH Capital Management LLC Has $5.83 Million Stock Position in PolyPid Ltd. $PYPD - MarketBeat
PolyPid to Present Data from SHIELD II Phase 3 Trial Demonstrating Reduced Severity of Surgical Site Infection at Surgical Infection Society 2026 Annual Meeting - BioSpace
PolyPid to present wound infection data at surgery conference By Investing.com - Investing.com South Africa
PolyPid to present wound infection data at surgery conference - Investing.com
PolyPid to Present Data from SHIELD II Phase 3 Trial - GlobeNewswire
PYPD Price Today: PolyPid Ltd. Stock Price, Quote & Chart | MEXC - MEXC Exchange
Short Interest in PolyPid Ltd. (NASDAQ:PYPD) Increases By 166.1% - MarketBeat
PYPD (PolyPid Ltd. Ordinary Shares) reports wider than expected Q4 2025 loss, yet shares rise modestly in today’s trading.Pro Trader Recommendations - Cổng thông tin điện tử tỉnh Tây Ninh
PolyPid (PYPD) Stock Outlook | Q4 2025: Earnings UnderperformHigh Growth - Cổng thông tin điện tử tỉnh Lào Cai
PolyPid Ltd stock (US70450B1035): Is its drug-delivery tech strong enough to unlock biotech upside? - AD HOC NEWS
PolyPid Ltd stock (US70450B1035): Is its drug delivery tech strong enough to unlock surgical market - AD HOC NEWS
Nir Dror Darwish Net Worth (2026) - GuruFocus
Itzhak Krinsky Net Worth (2026) - GuruFocus
PolyPid (PYPD) Stock Recovery Underway (-1.27%) 2026-04-16Hot Momentum Watchlist - Cổng thông tin điện tử tỉnh Lào Cai
Yechezkel Barenholz Net Worth (2026) - GuruFocus
Dikla Czaczkes Akselbrad Net Worth (2026) - GuruFocus
Jonathan Missulawin Net Worth (2026) - GuruFocus
Yitzchak Shlomo Jacobovitz Net Worth (2026) - GuruFocus
PolyPid To Present Phase 3 SHIELD II Data Showing Sustained Local Doxycycline Release And Minimal Systemic Exposure At ESCMID 2026 Conference - Sahm
Roth MKM Maintains PolyPid(PYPD.US) With Buy Rating, Maintains Target Price $9 - Moomoo
PolyPid to present D-PLEX100 pharmacokinetic data at ESCMID Global By Investing.com - Investing.com Australia
PolyPid to Present New Phase 3 SHIELD II Data Demonstrating D-PLEX₁₀₀ Sustained Local Release at ESCMID Global 2026 - markets.businessinsider.com
PolyPid to present D-PLEX100 pharmacokinetic data at ESCMID Global - Investing.com
2.98%
1.33%
大文字化:
|
ボリューム (24 時間):